Bookmark

Add to MyYahoo RSS

Cephalon News

News on Cephalon (Ticker: CEPH) continually updated from thousands of sources around the net.

Jun 25, 2014 | JD Supra

Court Report - June 2014 #4

Cephalon Inc. v. Actavis Laboratories FL Inc. et al. 1:14-cv-00776; filed June 19, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Duragesic, Fentanyl (generic), Health, Pain, Cancer, Solve, Eons

Tue Jun 24, 2014

BioSpace

How I Survived The Topsy-Turvy Pharmaceutical Industry

With Pfizer's attempted takeover of AstraZeneca, Merck & Co.' s continued downsizing, and the recent acquisition of Cephalon Inc., the Philadelphia region's pharmaceutical sector is going through some big changes.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Outsourcing

Mon Jun 23, 2014

Freshnews

Aratana Therapeutics Adds Robert P. Roche, Jr. to Board of Directors

Aratana Therapeutics, Inc. , a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced the appointment of former Cephalon, Inc., executive Robert P. Roche, Jr. to its Board of Directors.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Corporate Governance, Marketing

Freshnews

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV Anda...

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride powder for IV , 25 mg/vial and 100 mg/vial, a generic version of Treanda by Cephalon, Inc. On May 27, 2014, Cephalon, Inc. filed a Paragraph IV lawsuit against Breckenridge and its development and ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Leukemia, Health, Lymphoma

Thu Jun 05, 2014

Courthouse News Service

Teva Dodges Suit Over Marketing of Fentora

Cephalon and Teva Pharmaceuticals need not face racketeering claims over their off-label promotion of the addictive painkiller Fentora, a federal judge ruled.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cephalon, Marketing, Healthcare Law, Law, Duragesic, Fentanyl (generic), Morphine (generic), MS Contin, Kadian

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••